Description

Loprazolam is an imidazobenzodiazepine with anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties. It is indicated for the short-term treatment of insomnia including difficulty in falling asleep and/or frequent nocturnal awakenings. Loprazolam is recommended as a short-term therapy only, due to adverse events associated with the drug including dependence and withdrawal symptoms. It is a positive modulator of GABA-A receptor that enhances the inhibitory neurotransmission. It is not an FDA-approved drug.[DRUGBANK: DB13643] Source: Regenstrief LOINC

Basic Part Properties

Part Name
Loprazolam
Part Display Name
Loprazolam
Part Type
Component (Describes the core component or analyte measured)
Created On
2020-07-14
Construct for LOINC Short Name
Loprazolam

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP419634-3
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP419634-3

Language Variants Get Info

TagLanguageTranslation
fr-FRFrench (France)Loprazolam
it-ITItalian (Italy)Loprazolam
nl-NLDutch (Netherlands)loprazolam
es-ESSpanish (Spain)Loprazolam
zh-CNChinese (China)氯普唑仑
Synonyms: CAS 61197-73-7
el-GRGreek (Greece)Λοπραζολάμη
Synonyms: Λοπραζολάμη